Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-06-07

FDA Approved: OXALIPLATIN — Original Application (Qilu Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approved the original application for Oxaliplatin from Qilu Pharmaceutical Co., Ltd., a generic injectable anticancer drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

ORIG AP for OXALIPLATIN (OXALIPLATIN)